SAIRA CHOUDHRY: Open Payments
NPI 1952685711 · ADDISON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,676 in 85 payments from 15 companies in 2025. Trend: 2023 $331 · 2024 $1,490 · 2025 $1,676
Food & beverage: $1,676
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 19 | $329 |
| ABBVIE INC. | 11 | $232 |
| Axsome Therapeutics, Inc. | 5 | $162 |
| Teva Pharmaceuticals USA, Inc. | 9 | $160 |
| Lundbeck LLC | 8 | $147 |
| Otsuka America Pharmaceutical, Inc. | 6 | $138 |
| Tris Pharma Inc | 6 | $112 |
| E.R. Squibb & Sons, L.L.C. | 5 | $92 |
| Almatica Pharma LLC | 4 | $82 |
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
Products named: INGREZZA, VRAYLAR, REXULTI, Auvelity, AUSTEDO XR, ABILIFY ASIMTUFII, Dyanavel XR, COBENFY.
Industry payments across IL — which companies pay providers there.
